Colon Cancer

Posted on Posted in studies

Current data from a clinical study on patients with colon cancer shows that ProBion changes the bacterial profile in the colon to a profile similar to healthy individuals as well as changes the methylation pattern in the tumour cells, which could result in activation of tumour suppressor genes.